Title:
腫瘍の処置及び可視化における生体分子標的の使用法
Document Type and Number:
Japanese Patent JP2005523687
Kind Code:
A
Abstract:
The present invention relates to the use of a protein that is differentially expressed in primary brain tumor tissues, as compared to normal brain tissues, as a biomolecular target for tumor treatment therapies. The protein is also expressed in tissues from adenocarcinoma, non-melanoma, and renal carcinoma cells. Immunotherapeutic and immunoimaging agents that specifically bind to an identified brain tumor target protein are provided. The present invention also provides compounds and pharmaceutically acceptable compositions for administration in the methods of the invention.
Inventors:
Gonzales-Zuleta Millera
Mueller Sabin
Fore eric
Chin Daniel
Mueller Sabin
Fore eric
Chin Daniel
Application Number:
JP2003557507A
Publication Date:
August 11, 2005
Filing Date:
December 23, 2002
Export Citation:
Assignee:
AG Therapeutics Incorporated
International Classes:
G01N33/50; A61B10/00; A61K39/39; A61K39/395; A61K47/48; A61K48/00; A61K49/00; A61K49/04; A61K51/00; A61P1/14; A61P3/00; A61P9/10; A61P9/14; A61P15/00; A61P21/00; A61P21/04; A61P25/00; A61P25/04; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P25/30; A61P25/32; A61P27/00; A61P31/00; A61P31/10; A61P31/12; A61P33/00; A61P35/00; A61P41/00; A61P43/00; C12N1/21; C12N15/09; C12N15/12; C12Q1/02; C12Q1/68; G01N33/15; G01N33/574; (IPC1-7): C12Q1/68; A61B10/00; A61K39/39; A61K39/395; A61K47/48; A61K48/00; A61K49/00; A61K49/04; A61K51/00; A61P1/14; A61P3/00; A61P9/10; A61P9/14; A61P15/00; A61P21/00; A61P21/04; A61P25/00; A61P25/04; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P25/30; A61P25/32; A61P27/00; A61P31/00; A61P31/10; A61P31/12; A61P33/00; A61P35/00; A61P41/00; A61P43/00; C12Q1/02; G01N33/15; G01N33/50
Attorney, Agent or Firm:
Hatsushi Shimizu
Koichi Niimi
Koichi Niimi